Meetings – NO-AD

27-28 November 2025
On-line (Zoom) and in-person, with free registration.
–> In-Person Registration Link
–> Zoom only registration
* If you plan to use both in-person and Zoom, please register using both links.
Location: Domus Medica, Auditorium L-200
Address: Sognsvannsveien 9, 0372 Oslo, Norway

Organizers:
Evandro F. Fang-Stavem (Oslo, Norway)
Lynne Cox (Oxford, UK)
Richard Siow (KCL, UK)

Co-organizers:
Hong Kong Longevity Science Laboratory (Hong Kong)
Linda Bergersen, Jon Storm-Mathisen, Hilde Nilsen (UiO, Norway)
Per Nilsson (KI, Sweden) Asgeir Kobro-Flatmoen (NTNU, Norway)

The ageing population is growing rapidly across the Nordic countries and beyond, leading to increased healthcare and socioeconomic challenges. Ageing is the primary risk factor for many diseases, including neurodegenerative diseases such as Alzheimer’s disease (AD). Our understanding of the molecular mechanisms underlying brain ageing and neurodegeneration remains limited. Norway and the UK have a long-standing tradition in scientific collaborartions, especially in the neuroscience area. To address this critical knowledge gap, the Norway-UK Meetings on Ageing and Dementia will provide a dedicated space for researchers to discuss cutting-edge advancements in ageing and dementia, fostering collaboration across disciplines.

Held in Norway and the UK, the meeting series will bring together leaders in the fields to explore key topics, including molecular mechanisms of ageing, multi-omics approaches, artificial intelligence applications, neurodegeneration, and translational drug development. Speakers are leaders in these fields around the world! The meeting series will also strongly support young researchers by reserving space for short talks and a poster session, ensuring the next generation of scientists to play active roles in advancing the field. By facilitating interdisciplinary discussions and collaborations, we aim to drive innovation towards a future of healthy ageing and improved treatments for age-related diseases.

This 3^rd Norway-UK meeting on ageing and dementia will be focused on autophagy, in addition to cover other related topics. We thank our platinum sponsor Hong Kong Longevity Science Laboratory.

Evandro F. Fang-Stavem (University of Oslo, Norway)
Lynne Cox (University of Oxford, UK)
Richard Siow (King´s College London, UK)

Programme: Download the Programme (2025-11-25 version)

Abstract: You are welcome to submit your abstract by 2 Nov 2025 using our template.

Poster: You are welcome to present posters at our meeting (Template for posters on page 13). The THREE best presenters selected will receive awards of 10, 000 NOK each (supported by NO-Age, see Appendix 4).

Additional information:
1. The 1st Norway-UK meeting on ageing and dementia: Here, and scientific meeting summary here
2. The 2nd Norway-UK meeting on ageing and dementia: Here

Four years ago, colleagues from the Charles University (Martin Vyhnálek and Kateřina Veverová) and the University of Oslo (UiO) (Evandro Fang) secured a competitive grant of € 1 404 000 on the project entitled ‘The Validation of specific mitophagy biomarkers across Alzheimer’s disease continuum’ (acronym MIT-AD), from Iceland, Liechtenstein and Norway through the EEA Grants and the Technology Agency of the Czech Republic within the KAPPA Programme.

On 11 April 2024, in the old university campus of Charles University (founded 1348), a one-day meeting entitled “From Mitophagy to Neurocognitive Impairment“ was organized. This meeting aimed to share the exciting research data the MIT-AD team generated as well as to have leading experts in the fields to share their works to the community.

Highlights of some of the topics:

NO-Age international member, keynote speaker Prof. Nektarios Tavernarakis shared the mechanisms of compromised mitochondrial homeostasis in ageing and dementia! Prof. Martin Vyhnálek and Dr. Kateřina Veverová reported the results of changes of a few mitophagy proteins in blood and CSF samples from AD patients; the paper was just accepted in a leading journal, with news release shortly. Prof. Evandro Fang presented a talk entitled ‘The ‘5As’: ageing, Alzheimer’s disease, autophagy, AI, and an ‘A’ molecule in brain health and longevity’. DPhil student Johannes Frank (UiO) talked on a novel cellular death pathway in Alzheimer’s disease. Young researcher Dr. Sofie Hindkjær Lautup showed the use of AI in identifying unknown causes of neurodegenerative diseases. Dr. Davide D’Amico gave a talk on ‘Health benefits of the mitophagy activator Urolithin A – From preclinical models to clinical studies’.

More details of the meeting and the MIT-AD team: Charles University website and MIT-AD website

See pictures of the event below (copy right of the Photos: Charles University).